Connection

Julie Ann Justo to Middle Aged

This is a "connection" page, showing publications Julie Ann Justo has written about Middle Aged.
Connection Strength

0.272
  1. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50.
    View in: PubMed
    Score: 0.043
  2. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
    View in: PubMed
    Score: 0.042
  3. Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjects. Antimicrob Agents Chemother. 2015 Jul; 59(7):3956-65.
    View in: PubMed
    Score: 0.036
  4. Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literature. Int J Antimicrob Agents. 2020 Nov; 56(5):106158.
    View in: PubMed
    Score: 0.013
  5. Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study. Infection. 2020 Feb; 48(1):129-132.
    View in: PubMed
    Score: 0.012
  6. Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.
    View in: PubMed
    Score: 0.012
  7. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
    View in: PubMed
    Score: 0.012
  8. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
    View in: PubMed
    Score: 0.012
  9. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.
    View in: PubMed
    Score: 0.011
  10. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
    View in: PubMed
    Score: 0.010
  11. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
    View in: PubMed
    Score: 0.010
  12. Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
    View in: PubMed
    Score: 0.010
  13. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
    View in: PubMed
    Score: 0.010
  14. Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
    View in: PubMed
    Score: 0.010
  15. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
    View in: PubMed
    Score: 0.010
  16. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616.
    View in: PubMed
    Score: 0.010
  17. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.